DK1624057T3 - Hyaluronidaseholdigt præparat samt dets farmaceutiske anvendelse - Google Patents

Hyaluronidaseholdigt præparat samt dets farmaceutiske anvendelse

Info

Publication number
DK1624057T3
DK1624057T3 DK05090293T DK05090293T DK1624057T3 DK 1624057 T3 DK1624057 T3 DK 1624057T3 DK 05090293 T DK05090293 T DK 05090293T DK 05090293 T DK05090293 T DK 05090293T DK 1624057 T3 DK1624057 T3 DK 1624057T3
Authority
DK
Denmark
Prior art keywords
fraction
hyaluronidase
well
purified
pharmaceutical use
Prior art date
Application number
DK05090293T
Other languages
Danish (da)
English (en)
Inventor
Below Gudrun Von
Bernhard Schweigle
Bernd Goericke
Original Assignee
Riemser Arzneimittel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7833389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1624057(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Riemser Arzneimittel Ag filed Critical Riemser Arzneimittel Ag
Application granted granted Critical
Publication of DK1624057T3 publication Critical patent/DK1624057T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2474—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK05090293T 1997-06-17 1998-06-15 Hyaluronidaseholdigt præparat samt dets farmaceutiske anvendelse DK1624057T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19726626A DE19726626C1 (de) 1997-06-17 1997-06-17 Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats

Publications (1)

Publication Number Publication Date
DK1624057T3 true DK1624057T3 (da) 2008-09-15

Family

ID=7833389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05090293T DK1624057T3 (da) 1997-06-17 1998-06-15 Hyaluronidaseholdigt præparat samt dets farmaceutiske anvendelse

Country Status (6)

Country Link
EP (2) EP1624057B1 (cs)
AT (2) ATE323760T1 (cs)
CZ (1) CZ289560B6 (cs)
DE (3) DE19726626C1 (cs)
DK (1) DK1624057T3 (cs)
ES (2) ES2306004T3 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866120A (en) 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
US6610292B2 (en) 1995-11-22 2003-08-26 Ista Pharmaceuticals, Inc. Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
DE19726626C1 (de) * 1997-06-17 1998-09-03 Pharma Dessau Gmbh Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats
EP1616004A1 (en) * 2003-04-15 2006-01-18 Ista Pharmaceuticals, Inc Process for isolating and purifing ovine hyaluronidase
CN103725659A (zh) * 2013-11-24 2014-04-16 青岛康原药业有限公司 一种从牛睾丸中提取玻璃酸酶的方法
DE102015107307B3 (de) * 2015-05-11 2016-09-08 Labor L + S Aktiengesellschaft Optisches Verfahren zur Gehaltsbestimmung von Hyaluronsäure

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD24229A (cs) *
US3708575A (en) * 1970-05-13 1973-01-02 Biorex Laboratories Ltd Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase
RU2027759C1 (ru) * 1992-02-03 1995-01-27 Пак Владимир Николаевич Способ получения гиалуронидазы
RU2054943C1 (ru) * 1992-03-30 1996-02-27 Харьковское предприятие по производству иммунобиологических и лекарственных препаратов "Биолек" Способ получения гиалуронидазы
US5747027A (en) * 1995-04-07 1998-05-05 The Regents Of The University Of California BH55 hyaluronidase
US5958750A (en) * 1996-07-03 1999-09-28 Inctye Pharmaceuticals, Inc. Human hyaluronidase
DE19726626C1 (de) * 1997-06-17 1998-09-03 Pharma Dessau Gmbh Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats

Also Published As

Publication number Publication date
DE59813491D1 (de) 2006-05-24
EP1624057A2 (de) 2006-02-08
EP0892045A3 (de) 2001-02-07
ES2306004T3 (es) 2008-11-01
EP0892045A2 (de) 1999-01-20
ATE398171T1 (de) 2008-07-15
EP1624057B1 (de) 2008-06-11
EP1624057A3 (de) 2007-03-07
DE59814240D1 (de) 2008-07-24
ATE323760T1 (de) 2006-05-15
CZ191098A3 (cs) 1999-01-13
ES2263190T3 (es) 2006-12-01
EP0892045B1 (de) 2006-04-19
DE19726626C1 (de) 1998-09-03
CZ289560B6 (cs) 2002-02-13

Similar Documents

Publication Publication Date Title
ATE124997T1 (de) Enzymatische entfernung einer aminoterminalen proteinsequenz.
IE810433L (en) A specific cleavage linker
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
ATE234108T1 (de) Therapeutikum zur unterdrückung von schnarchgeräuschen
EP1396542A3 (en) P-Selectin Ligand Protein
BG106768A (en) Process for the purification of pharmacologically active proteins by cation-exchange chromatography
CA2259499A1 (en) Process for separating alpha-1-proteinase inhibitor from cohn fraction iv1 +iv4 paste
DK450785A (da) Fremgangsmaade til fremstilling af et koncentrat af antihaemofilisk faktor med hoej renhed
EP0111389A3 (en) Substantially pure porcine growth hormone, dna sequences therefor, and expression vehicles and transfected microorganisms for the production of porcine growth hormone
DK1624057T3 (da) Hyaluronidaseholdigt præparat samt dets farmaceutiske anvendelse
WO1995030001A3 (en) Novel p-selectin ligand protein
DE69837719D1 (de) Herstellungsverfahren von lactalbumin
WO1997003204A3 (de) (s)-hydroxynitrillyase aus hevea brasiliensis
EP0373540A3 (en) Method for purifying fibroblast growth factor protein
EP0199568A3 (en) Method for purifying interferon and composition of matter produced thereby
RU96115481A (ru) Способ лечения деформирующего остеоартроза крупных суставов
WO1998051780A3 (en) Method for increasing yields or recombinant proteins
BG47043A3 (bg) Метод за изолиране на d-аминокиселинна оксидаза
EP0881208A4 (en) NAPHTHALINDICARBONIC ACID PARTICLES AND METHOD FOR THE PRODUCTION THEREOF
NZ516235A (en) Method for purification of proteins
JPS55127988A (en) Preparation of peptidase
DE3270177D1 (en) Process for purifying elastase
EP0446850A3 (en) Process for purifying recombinant human beta-interferon
王榕树 et al. Physicochemical Behaviour and Removal of Lead in Water
AU8941091A (en) Method for purifying concentrated, aqueous and used solutions of chromic acid, and solutions thereby purified